Format

Send to

Choose Destination
Clin Infect Dis. 2013 Dec;57(12):1786-7. doi: 10.1093/cid/cit565. Epub 2013 Sep 17.

Screening with serum galactomannan might be associated with better outcome than symptom-triggered galactomannan testing in allogeneic HSCT recipients with invasive aspergillosis.

Author information

1
Division of Infectious Diseases, San Martino University Hospital and Department of Health Sciences, University of Genoa.

Comment in

PMID:
24046295
DOI:
10.1093/cid/cit565
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center